| Next revision | Previous revisionBoth sides next revision |
alberta_innovates [2022/10/26 21:46]
liam created | alberta_innovates [2024/07/17 17:46] (current)
liam [Subsidiaries] |
|---|
| {{ ::ai-logo-vertical_colour.jpeg?200|}} | {{ ::ai-logo-vertical_colour.jpeg?200|}} |
| |
| | **Alberta Innovates** is a Canadian provincial government agency owned and operated by the Province of [[canada:Alberta]]. |
| | |
| | ===== History ===== |
| | |
| | In 2011, Alberta Innovates partnered with [[pharmaceutical_companies:Pfizer]], the [[Alberta Ministry of Economic Development and Trade]] and [[Western Economic Diversification Canada]] to create and co-manage the Alberta/Pfizer Translational Research Collaboration Fund. Later renamed to the Pfizer-Alberta Collaboration in Health, the fund totaled $3.5 million in 2013. |
| | |
| | In November 2018, Pfizer and the [[Government of Alberta]] announced an additional $1.3 million contribution to the fund. This brought the fund value at the time to over $4.8 million.((Brunner, D. (2018, November 26). //Alberta Government and Pfizer Canada boosts provincial collaborative health innovation partnership with Alberta Innovates.// Alberta Innovates. https://archive.ph/1ppaw)) |
| | |
| | ==== COVID-19 ==== |
| | |
| | In September 2020, Alberta Innovates announced $2.1 million in funding for [[COVID-19]] research. Seven projects were selected for funding out of a pool of 28 applicants:((Semeniuk, R. (2020, September 10). //Alberta Innovates injects $2.1 M into COVID Research.// Alberta Innovates. https://web.archive.org/web/20221026201102/https://albertainnovates.ca/impact/newsroom/alberta-innovates-injects-2-1-million-into-covid-research/)) |
| | |
| | ^ Principal Investigator ^ Organization ^ Title ^ Funding ^ |
| | | [[Jie Chen]] | [[University of Alberta]] | Development and Clinical Validation of a Rapid Antibody Detection Device for COVID-19 | $304,200 | |
| | | [[Andrei Drabovich]] | University of Alberta | Rational design and standardization of serology diagnostics using immunoaffinity-targeted proteomics assays | $182,098 | |
| | | [[Matthias Hoben]] | University of Alberta | COVID-19 and Caregivers of Assisted living Residents: their Experiences and Support needs (COVCARES-AB/BC) | $328,376 | |
| | | [[Jia Hu]] | [[University of Calgary]] | Changing COVID-19 Behaviors through a data-driven targeted marketing campaign ([[19 to Zero]]) | $392,080 | |
| | | [[Mark Lewis]] | University of Alberta | Predicting and managing COVID-19 pandemic dynamics using machine learning | $220,545 (supported through the Pfizer-Alberta Collaboration in Health) | |
| | | [[Ken Parhar]] | University of Calgary | The Evaluation of a PRONe Positioning Knowledge Translation Toolkit in COVID-19 ARDS (PRONTO) study | $362,285 | |
| | | [[Puneeta Tandon]] | University of Alberta | Reconnecting vulnerable outpatients with multidisciplinary care – an RCT assessing online programming in the time of COVID-19 | $326,297 | |
| | ===== Organization ===== |
| | |
| | ==== Subsidiaries ==== |
| | |
| | AI operates two subsidiary companies; [[C-FER Technologies]] and [[InnoTech Alberta]]. It also runs the [[Alberta Foundation for Health Research]].((//Alberta Foundation For Health Research.// Charitable Impact. Retrieved October 26, 2022, from https://archive.ph/7dBQu)) |
| | |
| | C-FER works in partnership with the global energy industry, while InnoTech works with environmental, biological, and energy technology companies. |
| | |
| | ===== External links ===== |
| | |
| | * [[https://wiki.whiteroseintelligence.com/en/Alberta-Innovates|White Rose Wiki]] |
